Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claire Reid

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
American Heart Journal|April 24, 2012
Preventing cardiovascular disease in primary care: role of a national risk factor management programEmer R McGrath, Liam G Glynn, Andrew W Murphy, et al.
Clinical Chemistry|August 21, 2003
Sensitivity and specificity of the Cozart microplate EIA cocaine oral fluid at proposed screening and confirmation cutoffsInsook Kim, Allan J Barnes, Raf Schepers, et al.
Journal of Analytical Toxicology|November 11, 2003
Sensitivity, specificity, and efficiency in detecting opiates in oral fluid with the Cozart Opiate Microplate EIA and GC-MS following controlled codeine administrationAllan J Barnes, Insook Kim, Raf Schepers, et al.
Iscience|February 15, 2020
DNMT3B Oncogenic Activity in Human Intestinal Cancer Is Not Linked to CIMP or BRAFV600E MutationDouglas J MacKenzie, Neil A Robertson, Iqbal Rather, et al.
Journal of Analytical Toxicology|November 11, 2003
Cozart RapiScan Oral Fluid Drug Testing System: an evaluation of sensitivity, specificity, and efficiency for cocaine detection compared with ELISA and GC-MS following controlled cocaine administrationErin A Kolbrich, Insook Kim, Allan J Barnes, et al.
Forensic Science International|April 7, 2004
Performance characteristics of the Cozart RapiScan Oral Fluid Drug Testing System for opiates in comparison to ELISA and GC/MS following controlled codeine administrationSherri L Kacinko, Allan J Barnes, Insook Kim, et al.
The Lancet. Rheumatology|June 14, 2024
The time of equipoise on the use of biological DMARDs in for inflammatory arthritis during pregnancy is finally over: a reappraisal of evidence to optimise pregnancy managementIan Giles, Iona Thorne, Nanna Surlemont Schmidt, et al.
The Journal of Investigative Dermatology|April 13, 2021
ENTPD1 (CD39) Expression Inhibits UVR-Induced DNA Damage Repair through Purinergic Signaling and Is Associated with Metastasis in Human Cutaneous Squamous Cell CarcinomaMelodi Javid Whitley, Jutamas Suwanpradid, Chester Lai, et al.
Aging Cell|July 16, 2025
Inactivation of Histone Chaperone HIRA Unmasks a Link Between Normal Embryonic Development of Melanoblasts and Maintenance of Adult Melanocyte Stem CellsFarah Jaber-Hijazi, Rouven Arnold, Karthic Swaminathan, et al.
Nature Communications|January 12, 2021
BRD4-mediated repression of p53 is a target for combination therapy in AMLAnne-Louise Latif, Ashley Newcombe, Sha Li, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
American Heart Journal|April 24, 2012
Preventing cardiovascular disease in primary care: role of a national risk factor management programEmer R McGrath, Liam G Glynn, Andrew W Murphy, et al.
Clinical Chemistry|August 21, 2003
Sensitivity and specificity of the Cozart microplate EIA cocaine oral fluid at proposed screening and confirmation cutoffsInsook Kim, Allan J Barnes, Raf Schepers, et al.
Journal of Analytical Toxicology|November 11, 2003
Sensitivity, specificity, and efficiency in detecting opiates in oral fluid with the Cozart Opiate Microplate EIA and GC-MS following controlled codeine administrationAllan J Barnes, Insook Kim, Raf Schepers, et al.
Iscience|February 15, 2020
DNMT3B Oncogenic Activity in Human Intestinal Cancer Is Not Linked to CIMP or BRAFV600E MutationDouglas J MacKenzie, Neil A Robertson, Iqbal Rather, et al.
Journal of Analytical Toxicology|November 11, 2003
Cozart RapiScan Oral Fluid Drug Testing System: an evaluation of sensitivity, specificity, and efficiency for cocaine detection compared with ELISA and GC-MS following controlled cocaine administrationErin A Kolbrich, Insook Kim, Allan J Barnes, et al.
Forensic Science International|April 7, 2004
Performance characteristics of the Cozart RapiScan Oral Fluid Drug Testing System for opiates in comparison to ELISA and GC/MS following controlled codeine administrationSherri L Kacinko, Allan J Barnes, Insook Kim, et al.
The Lancet. Rheumatology|June 14, 2024
The time of equipoise on the use of biological DMARDs in for inflammatory arthritis during pregnancy is finally over: a reappraisal of evidence to optimise pregnancy managementIan Giles, Iona Thorne, Nanna Surlemont Schmidt, et al.
The Journal of Investigative Dermatology|April 13, 2021
ENTPD1 (CD39) Expression Inhibits UVR-Induced DNA Damage Repair through Purinergic Signaling and Is Associated with Metastasis in Human Cutaneous Squamous Cell CarcinomaMelodi Javid Whitley, Jutamas Suwanpradid, Chester Lai, et al.
Aging Cell|July 16, 2025
Inactivation of Histone Chaperone HIRA Unmasks a Link Between Normal Embryonic Development of Melanoblasts and Maintenance of Adult Melanocyte Stem CellsFarah Jaber-Hijazi, Rouven Arnold, Karthic Swaminathan, et al.
Nature Communications|January 12, 2021
BRD4-mediated repression of p53 is a target for combination therapy in AMLAnne-Louise Latif, Ashley Newcombe, Sha Li, et al.
Pageof 2